G M Chisolm 3rd
Overview
Explore the profile of G M Chisolm 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chisolm 3rd G, Chai Y
Free Radic Biol Med
. 2000 Aug;
28(12):1697-707.
PMID: 10946211
The first reports of the influences of oxidized LDL (oxLDL) on cell function pertained to negative effects on cell growth-growth arrest, injury, and toxicity. Since these studies, it has become...
2.
Chisolm 3rd G, Hazen S, Fox P, Cathcart M
J Biol Chem
. 1999 Sep;
274(37):25959-62.
PMID: 10473535
No abstract available.
3.
Cathcart M, Li Q, Chisolm 3rd G
J Lipid Res
. 1995 Sep;
36(9):1857-65.
PMID: 8558074
Upon activation, human peripheral blood monocytes and U937 cells oxidized low density lipoprotein (LDL), converting it to a cytotoxin. The oxidized LDL loses its ability to interact specifically with the...
4.
Morris E, Saidel G, Chisolm 3rd G
Am J Physiol
. 1991 Sep;
261(3 Pt 2):H929-49.
PMID: 1887937
To quantify transport processes in atherosclerosis, the arterial wall is often exposed to labeled lipoproteins. In vivo experiments are desirable for estimation of transport parameters, but they are technically difficult....
5.
Chisolm 3rd G
Clin Cardiol
. 1991 Feb;
14(2 Suppl 1):I25-30.
PMID: 2044256
Numerous recently published studies demonstrate that, once altered by free radical oxidation, plasma lipoproteins undergo dramatic change, both in the manner in which they can interact with cells and in...
6.
McNally A, Chisolm 3rd G, Morel D, Cathcart M
J Immunol
. 1990 Jul;
145(1):254-9.
PMID: 2162888
Monocyte-mediated oxidation of low-density lipoprotein (LDL) converts the lipoprotein to a potent cytotoxin. The oxidation process requires monocyte activation and requires superoxide anion since it can be blocked by superoxide...
7.
Hoff H, ONeil J, Chisolm 3rd G, Cole T, Quehenberger O, Esterbauer H, et al.
Arteriosclerosis
. 1989 Jul;
9(4):538-49.
PMID: 2751482
There is indirect evidence that the oxidation of low density lipoprotein (LDL) may be involved in the development of atherosclerosis. Modification of LDL by oxidation may lead to its unregulated...
8.
Cathcart M, McNally A, Morel D, Chisolm 3rd G
J Immunol
. 1989 Mar;
142(6):1963-9.
PMID: 2537865
Human monocytes, upon activation with opsonized zymosan, altered low-density lipoprotein (LDL) during a 24-h co-incubation, resulting in its oxidation and acquisition of cytotoxic activity against target fibroblast cell lines. Both...
9.
Cathcart M, Chisolm 3rd G, McNally A, Morel D
In Vitro Cell Dev Biol
. 1988 Oct;
24(10):1001-8.
PMID: 3182552
Human peripheral blood monocytes, upon activation, have the capacity to oxidize low density lipoprotein (LDL) and render the LDL toxic to cultured cells. Previous studies by our laboratory indicate that...
10.
Chisolm 3rd G, Morel D
Am J Cardiol
. 1988 Jul;
62(3):20B-26B.
PMID: 3394649
For a number of years, the cell-damaging effects of oxidized low-density lipoproteins (LDL) have been studied. Oxidized LDL-induced tissue damage may be important in vivo; there is mounting evidence for...